Publications


Transcriptomique et épissage dans le cancer

2024

MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer.
Quesnel-Vallières M, Jewell S, Lynch KW, Thomas-Tikhonenko A, Barash Y
Nucleic Acids Research

Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia Quesnel-Vallières M, Schultz DC, Orlenko A, Lo Y, Moore J, Ritchie M, Roth D, Carroll M, Barash Y, Lynch KW, Cherry S Drugs in R&D

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.
Torres-Diz M, Reglero C, Falkenstein CD, Castro A, Hayer KE, Radens CM, Quesnel-Vallières M, Ang Z, Sehgal P, Li MM, Barash Y, Tasian SK, Ferrando A, Thomas-Tikhonenko A
Cancer Research

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.
Liu X, Devadiga SA, Stanley RF, Morrow RM, Janssen KA, Quesnel-Vallières M, Pomp O, Moverley AA, Li C, Skuli N, Carroll M, Huang J, Wallace DC, Lynch KW, Abdel-Wahab O, Klein PS
Journal of Clinical Investigation

2023

CHESSBOARD: a Bayesian model for unsupervised detection of alternative splicing based subtypes in heterogeneous cancers.
Wang D, Quesnel-Vallières M, Jewell P, Elzubeir M, Lynch KW, Thomas-Tikhonenko A, Barash Y
Nature Communications

2022

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance.
Cortés-López M, Schulz L, Enculescu M, Paret C, Spiekermann B, Busch A, Orekhova A, Kielisch F, Quesnel-Vallières M, Torres-Diz M, Faber J, Barash Y, Thomas- Tikhonenko A, Zarnack K, Legewie S, König J
Nature Communications

Identifying common transcriptome signatures of cancer by interpreting deep learning models.
Jha A*#, Quesnel-Vallières M*#, Thomas-Tikhonenko A, Lynch KW, Barash Y#
Genome Biology
* co-premiers auteurs
# auteurs de correspondance

Modulation of CD22 protein expression in childhood leukemia by pervasive splicing aberrations: implications for CD22-directed immunotherapies.
Zheng S, Gillespie E, Naqvi A, Hayer K, Ang Z, Torres-Diz M, Quesnel-Vallières M, Hottman D, Bagashev A, Chukinas J, Asnani M, Shraim R, Schmidt C, Taylor DM, Rheingold S.R, O’Brien MM, Singh N, Lynch K.W, Ruella M, Barash Y, Tasian SK, Thomas-Tikhonenko A
Blood Cancer Discovery

2021

Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
Rivera OD, Mallory MJ, Quesnel-Vallières M, Schultz D.C, Carroll M, Barash Y, Cherry S, Lynch KW
PNAS

Épissage alternatif dans les troubles de l’autisme

2020

Autism-misregulated eIF4G microexons control synaptic translation and higher order cognitive functions.
Gonatopoulos-Pournatzis T, Niibori R, Salter EW, Weatheritt RJ, Tsang B, Farhangmehr S, Liang X, Braunschweig U, Roth J, Zhang S, Henderson T, Sharma E, Quesnel- Vallières M, Permanyer J, Maier S, Georgiou J, Irimia M, Sonenberg N, Forman-Kay JD, Gingras AC, Collingridge GL, Woodin MA, Cordes SP, Blencowe BJ
Molecular Cell

2019

Autism Spectrum Disorder: Insights into convergent mechanisms from transcriptomics.
Quesnel-Vallières M#, Weatheritt RJ, Cordes SP#, and Blencowe BJ#
Nature Reviews Genetics
# corresponding authors
Article de couverture: NRG cover

2016

Misregulation of an activity-dependent splicing network as a common mechanism underlying autism spectrum disorders.
Quesnel-Vallières M, Dargaei Z, Irimia M, Gonatopoulos-Pournatzis T, Ip J, Wu M, Sterne-Weiler T, Nakagawa S, Woodin MA, Blencowe BJ, and Cordes SP
Molecular Cell
Article couvert par The Globe and Mail: Globe

2015

Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development.
Quesnel-Vallières M, Irimia M, Cordes SP, and Blencowe BJ
Genes and Development

2014

A highly conserved program of neuronal microexons is misregulated in autistic brains.
Irimia M, Weatheritt RJ, Ellis J, Parikshak NN, Gonatopoulos-Pournatzis T, Babor M, Quesnel-Vallières M, Tapial J, Raj B, O’Hanlon D, Barrios-Rodiles M, Sternberg MJ, Cordes SP, Roth FP, Wrana JL, Geschwind DH, and Blencowe BJ
Cell
Article souligné dans un Preview dans Cell, un Editor’s Choice dans Science et un Research Highlights dans Nature Genetics; couvert part des média internationaux (e.g Toronto Star, The Scientist)

Autres

2023

The Tumor Suppressor Adenomatous Polyposis Coli (apc) Is Required for Neural Crest-Dependent Craniofacial Development in Zebrafish. Liu X, Jones WD, Quesnel-Vallières M, Devadiga SA, Lorent K, Valvezan AJ, Myers RL, Li N, Lengner CJ, Barash Y, Pack M, Klein PS. Journal of Developmental Biology

2022

Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression.
Wakabayashi A, Kihiu M, Sharma M, Thrasher AJ, Saari MS, Quesnel-Vallières M, Abdulmalik O, Chou ST, Peslak SA, Khandros E, Keller CA, Giardine BM, Hardison RC, Shi J, Blobel GA
Blood Advances

2020

Rapid and scalable profiling of nascent RNA with fastGRO.
Barbieri E, Hill C, Quesnel-Vallières M, Zucco AJ, Barash Y, Gardini A
Cell Reports

2019

Missense mutations in NKAP cause a disorder of transcriptional regulation characterized by marfanoid habitus and cognitive impairment
Fiordaliso SK, Iwata-Otsubo A, Ritter AL, Quesnel-Vallières M, Fujiki K, Nishi E, Hancarova M, Miyake N, Morton JEV, Lee S, Hackmann K, Bando M, Masuda K, Nakato R, Arakawa M, Bhoj E, Li D, Hakonarson H, Takeda R, Harr M, Keena B, Zackai EH, Okamoto N, Mizuno S, Ko JM, Valachova A, Prchalova D, Vlckova M, Pippucci T, Seiler C, Choi M, Matsumoto N, Di Donato N, Barash Y, Sedlacek Z, Shirahige K, Izumi K
American Journal of Human Genetics

2017

An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms.
Tapial J, Ha KCH, Sterne-Weiler T, Gohr A, Braunschweig U, Hermoso-Pulido A, Quesnel-Vallières M, Permanyer J, Sodaei R, Marquez Y, Cozzuto L, Wang X, Gómez- Velázquez M, Rayon T, Manzanares M, Ponomarenko J, Blencowe BJ, and Irimia M
Genome Research